Catalent, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • September 9th, 2016 • Catalent, Inc. • Pharmaceutical preparations • New York
Catalent, Inc., a Delaware corporation (the “Company”), and the selling stockholders identified in the signature pages hereto (the “Selling Stockholders”), confirm their agreement with you, with respect to the sale by the Selling Stockholders to you (the “Underwriters”), of an aggregate of 18,991,827 shares of common stock, par value $0.01 per share (the “Stock”), of the Company. The aggregate of 18,991,827 shares of Stock to be sold by the Selling Stockholders are herein called the “Shares”. The terms “supplement,” “amendment” and “amend” as used herein with respect to the Registration Statement, the Preliminary Prospectus, the Prospectus or the Pricing Prospectus (each as defined below) shall include all documents subsequently filed by the Company with the Securities and Exchange Commission (“Commission”) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are incorporated by reference or deemed to be incorporated by reference therein under the Secu
